Sugi Predict

Sugi Predict / Compounds / SCHEMBL21652271

SCHEMBL21652271

SCHEMBL21652271

Cc1cc(C)cc(-c2ccccc2N[C@@H](c2ccccc2)[C@@H](Nc2ccccn2)c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC10A1 Q14973 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ MAPK10 P53779 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PLK1 P53350 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21652274 0.90 SLC10A1 (0.42) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652272 0.89 SLC10A1 (0.44) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652279 0.87 SLC10A1 (0.45) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652176 0.87 SLC10A1 (0.49) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL23772944 0.84 SLC10A1 (0.41) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652276 0.84 SLC10A1 (0.50) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652273 0.84 SLC10A1 (0.44) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652278 0.82 SLC10A1 (0.42) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652275 0.82 ATP1A1 (0.42) SLC10A1KDM4EHTTNPSR1L3MBTL1
SCHEMBL21652277 0.81 SLC10A1 (0.41) SLC10A1KDM4EHTTNPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161861-B2 Boron-nitrogen ligand with chiral 1,2-ethylenediamine backbone, and preparation method and use thereof Lanzhou Institute of Chemical Physics, Chinese Academy of Science (CN) 2021-11-02 — — US disclosed
US-20210253606-A1 BORON-NITROGEN LIGAND WITH CHIRAL 1,2-ETHYLENEDIAMINE BACKBONE, AND PREPARATION METHOD AND USE THEREOF SUZHOU RESEARCH INSTITUTE, LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2021-08-19 — — US disclosed
WO-2020019911-A1 BORON NITROGEN LIGAND BASED ON CHIRAL 1,2-ETHYLENEDIAMINE BACKBONE AND PREPARATION METHOD AND USE THEREOF 中国科学院兰州化学物理研究所苏州研究院 2020-01-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253606-A1 BORON-NITROGEN LIGAND WITH CHIRAL 1,2-ETHYLENEDIAMINE BACKBONE, AND PREPARATION METHOD AND USE THEREOF C3AR1, BDKRB1, BDKRB2 SLC10A1 1668/4885KDM4E 3984/4885HTT 1853/4885
US-11161861-B2 Boron-nitrogen ligand with chiral 1,2-ethylenediamine backbone, and preparation method and use thereof C3AR1, BDKRB1, BDKRB2 SLC10A1 1668/4885KDM4E 3984/4885HTT 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.